High expression of RUVBL1 and HNRNPU is associated with poor overall survival in stage I and II non-small cell lung cancer patients.

Durslewicz, Justyna; Józwicki, Jakub; Klimaszewska-Wisniewska, Anna; Zielinska, Aleksandra; Antosik, Paulina; Grzanka, Dariusz; Braun, Marcin

Durslewicz, Justyna; Józwicki, Jakub; Klimaszewska-Wisniewska, Anna; Zielinska, Aleksandra; Antosik, Paulina; Grzanka, Dariusz; Braun, Marcin.

Afiliação

Durslewicz J; Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
Józwicki J; Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
Klimaszewska-Wisniewska A; Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
Zielinska A; Department of Pathology, Chair of Oncology, Medical University of Lodz, Lodz, Poland.
Antosik P; Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
Grzanka D; Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
Braun M; Department of Pathology, Chair of Oncology, Medical University of Lodz, Lodz, Poland. braunmarcin@gmail.com.

Discov Oncol ; 13(1): 106, 2022 Oct 15.

Article em En | MEDLINE | ID: mdl-36242708

Palavras-chave

HNRNPU; NSCLC; Non-small cell lung cancer; Nuclear matrix protein; Prognostic biomarkers; RUVBL1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Discov Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google